BIOTECHNOLOGY VALUE FUND L P

Holdings History for Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)

Symbol: AVTX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 1,904,257 shares
Security Ownership %: 10%

BVF PARTNERS L P/IL ownership in Avalo Therapeutics, Inc. COMMON STOCK (AVTX)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,904,257 shares of Avalo Therapeutics, Inc. COMMON STOCK (AVTX). This represents 10% ownership of the company. In their previous filing dated 14 Nov 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 1,458,151 shares, indicating an increase of +31%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	10%	0%	$32,277,156	1,904,257	+446,106	+31%	$16.95	13G/A	31 Dec 2025	17 Feb 2026, 16:07
BVF PARTNERS L P/IL	10%	0%	$18,533,099	1,458,151	+419,609	+40%	$12.71	13G/A	30 Sep 2025	14 Nov 2025, 16:00
BVF PARTNERS L P/IL	10%		$5,192,710	1,038,542			$5.00	13G/A	31 Dec 2024	14 Feb 2025, 16:02